Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 5
1997 1
1998 2
1999 1
2000 3
2001 1
2004 1
2006 1
2007 1
2008 1
2011 1
2013 1
2014 2
2015 1
2016 1
2017 1
2018 1
2019 2
2020 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Results by year
Filters applied: . Clear all
Page 1
[Factor IX assays in treated hemophilia B patients].
Pouplard C, Jeanpierre E, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzallah I, Proulle V, Smahi M, Sobas F, Ternisien C, Toulon P, Voisin S, Nougier C; groupe d’études de la biologie des maladies hémorragiques du Groupe français d’études de l’hémostase et la thrombose. Pouplard C, et al. Among authors: eschwege v. Ann Biol Clin (Paris). 2019 Feb 1;77(1):41-52. doi: 10.1684/abc.2019.1414. Ann Biol Clin (Paris). 2019. PMID: 30799297 Free article. Review. French.
[Factor VIII assays in treated hemophilia A patients].
Lasne D, Pouplard C, Nougier C, Eschwege V, Le Cam Duchez V, Proulle V, Smahi M, Harzallah I, Voisin S, Toulon P, Sobas F, Galinat H, Flaujac C, Ternisien C, Jeanpierre E; groupe d'études de la biologie des maladies hémorragiques du Groupe français d'études de l'hémostase et la thrombose. Lasne D, et al. Among authors: eschwege v. Ann Biol Clin (Paris). 2019 Feb 1;77(1):53-65. doi: 10.1684/abc.2019.1413. Ann Biol Clin (Paris). 2019. PMID: 30799298 Free article. Review. French.
Impact of Geographic Region on the COMMANDER-HF Trial.
Ferreira JP, Cleland JGF, Lam CSP, van Veldhuisen DJ, Byra WM, La Police DA, Anker SD, Mehra MR, Leroy C, Eschwege V, Toussaint-Hacquard M, Rossignol P, Greenberg B, Zannad F. Ferreira JP, et al. Among authors: eschwege v. JACC Heart Fail. 2021 Mar;9(3):201-211. doi: 10.1016/j.jchf.2020.11.007. Epub 2021 Feb 3. JACC Heart Fail. 2021. PMID: 33549557 Free article.
Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
Jeanpierre E, Pouplard C, Lasne D, Le Cam Duchez V, Eschwege V, Flaujac C, Galinat H, Harzallah I, Proulle V, Smahi M, Sobas F, Stepina N, Toulon P, Voisin S, Ternisien C, Nougier C; French Study Group on the Biology of Hemorrhagic Diseases (the BIMHO group). Jeanpierre E, et al. Among authors: eschwege v. Eur J Haematol. 2020 Aug;105(2):103-115. doi: 10.1111/ejh.13423. Epub 2020 May 27. Eur J Haematol. 2020. PMID: 32277501 Review.
Thrombotic risk factors in pulmonary hypertension.
Wolf M, Boyer-Neumann C, Parent F, Eschwege V, Jaillet H, Meyer D, Simonneau G. Wolf M, et al. Among authors: eschwege v. Eur Respir J. 2000 Feb;15(2):395-9. doi: 10.1034/j.1399-3003.2000.15b28.x. Eur Respir J. 2000. PMID: 10706510 Free article.
Multicentre pharmacokinetic evaluation of rFVIII-Fc (efmoroctocog alfa) in a real life and comparison with non-extended half-life FVIII concentrates.
Pouplard C, Sattler L, Ryman A, Eschwege V, De Maistre E, Flaujac C, Szymezak J, Grand F, Repesse Y, Galinat H, Donnard M, Ternisien C, Iorio A, Chelle P, Jeanpierre E; ‘Biology Study Group on Haemorrhagic Diseases’ (Group BIMHO - GFHT). Pouplard C, et al. Among authors: eschwege v. Haemophilia. 2020 Mar;26(2):282-289. doi: 10.1111/hae.13946. Epub 2020 Feb 27. Haemophilia. 2020. PMID: 32107819
29 results